CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pharmacogenetics & Genomics

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/FPC.0b013e32835f834dPMID 23462429PMCID PMC3744214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic variation in CYP2A6 predicts neural reactivity to smoking cues as measured using fMRI

  2012cited by this paper
• Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended‐Duration Transdermal Nicotine Therapy

  2010cited by this paper
• The genetic aspects of nicotine metabolism and their impact on adolescent nicotine dependence

  2010cited by this paper
• What to Do about Missing Values in Time‐Series Cross‐Section Data

  2010cited by this paper
• Nicotine Dependence Pharmacogenetics: Role of Genetic Variation in Nicotine-Metabolizing Enzymes

  2009cited by this paper
• Determinants of first puff and daily cigarette smoking in adolescents.

  2009cited by this paper
• The Role of CYP2A6 in the Emergence of Nicotine Dependence in Adolescents

  2007cited by this paper
• CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

  2006cited by this paper
• Safety and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Addiction

  2005cited by this paper
• Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers

  2004cited by this paper

• Inhibitory effects of Δ8-tetrahydrocannabinol on nicotine metabolism and implications as a smoking cessation agent

  2026cites this paper
• A phenome-wide association study of genetically determined nicotine metabolism reveals novel links with health-related outcomes

  2025cites this paper
• Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community

  2025cites this paper
• Effect of very low nicotine content cigarettes on smoking behavior in Chinese smokers with genotype-stratified nicotine metabolism rates

  2025cites this paper
• The neurobiological and behavioral impacts of adulterants in drugs of abuse

  2025cites this paper
• Drug Metabolizing Enzymes: An Exclusive Guide into Latest Research in Pharmaco-genetic Dynamics in Arab Countries.

  2024cites this paper
• Association of monoaminergic gene polymorphisms in chronic inflammatory pulmonary disease patients with successful smoking cessation

  2024cites this paper
• Catecholamine levels with use of electronic and combustible cigarettes

  2024cites this paper
• PharmVar GeneFocus: CYP2A6

  2024cites this paper
• Pathogenic Missense Mutations in Nicotine-metabolizing Cytochrome P450 2A6 Gene – An In silico Study

  2024cites this paper
• Identification of non-adherence to adjuvant letrozole using a population pharmacokinetics approach in hormone receptor-positive breast cancer patients.

  2024cites this paper
• Genetic CYP2A6 Polymorphism May Worsen Glycohemoglobin Levels: Study among Javanese Indonesian Smokers

  2024cites this paper
• The Role of Nicotine Metabolic Rate on Nicotine Dependence and Rewarding: Nicotine Metabolism in Chinese Male Smokers and Male Mice

  2024cites this paper
• A Phenome-wide association study of a genetic score for the nicotine metabolite ratio

  2023cites this paper
• Effects ofGeneticVariants in theNicotineMetabolismPathwayon Smoking Cessation

  2022cites this paper
• Does genetic variation in a bitter taste receptor gene alter early smoking behaviors in adolescents and young adults?

  2022cites this paper
• "Genetic influences impacting nicotine use and abuse during adolescence: insights from human and rodent studies".

  2022cites this paper
• Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation

  2022cites this paper
• The promise of polygenic risk prediction in smoking cessation: Evidence from two treatment trials.

  2022cites this paper
• Impact Of Cyp2a6 Activity On Nicotine Reinforcement And Cue-Reactivity In Daily Smokers.

  2021cites this paper
• University of Groningen Postnatal Smoke Exposure Further Increases the Hepatic Nicotine Metabolism in Prenatally Smoke Exposed Male Offspring and Is Linked with Aberrant Cyp2a5 Methylation Lkhagvadorj,

  2021cites this paper
• Drug Metabolism: Cytochrome P450

  2021cites this paper
• Nicotine metabolism predicted by CYP2A6 genotypes in relation to smoking cessation: A systematic review.

  2021cites this paper
• Distribution of cytochrome P450*4 (CYP2A6*4) allele gene among Javanese Indonesian T2DM patients

  2021cites this paper
• ASSOCIATION BETWEEN SMOKING BEHAVIOUR AND GLYCOHEMOGLOBINE LEVELS AMONG ADULT JAVANESE INDONESIAN SMOKERS

  2020cites this paper
• Association between CYP2A6 genotypes and smoking behavior in Lebanese smokers

  2020cites this paper
• Urinary Cotinine as a Biomarker of Cigarette Smoke Exposure: A Method to Differentiate Among Active, Second-Hand, and Non-Smoker Circumstances

  2020cites this paper
• Predictors of Cigarette Smoking Cessation in Adolescents: A Systematic Review.

  2020cites this paper
• Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme

  2020cites this paper
• An Update on the Role of Common Genetic Variation Underlying Substance Use Disorders

  2020cites this paper
• New Biological Insights into Smoking Cessation

  2020cites this paper
• Postnatal Smoke Exposure Further Increases the Hepatic Nicotine Metabolism in Prenatally Smoke Exposed Male Offspring and Is Linked with Aberrant Cyp2a5 Methylation

  2020cites this paper
• The neurobiology of addiction

  2019cites this paper
• Genetic susceptibility to nicotine and/or alcohol addiction: a systematic review

  2019cites this paper
• Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy

  2019cites this paper
• Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science

  2018cites this paper
• CYP2A6 metabolism in the development of smoking behaviors in young adults

  2018cites this paper
• Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers

  2018cites this paper
• Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism

  2018cites this paper
• Airborne Nicotine, Secondhand Smoke, and Precursors to Adolescent Smoking

  2018cites this paper
• Preparing the Way: Exploiting Genomic Medicine to Stop Smoking.

  2018cites this paper
• Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment

  2018cites this paper
• Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV Implications for Treatment and Research

  2018cites this paper
• The effect of body mass index on smoking behaviour and nicotine metabolism: a Mendelian randomization study

  2018cites this paper
• Using Phytochemicals to Investigate the Activation of Nicotine Detoxification via Upregulation of CYP2A6 in Animal Models Exposed Tobacco Smoke Condensate by Intratracheal Instillation

  2018cites this paper
• Association and interplay of genetic and epigenetic variants in smoking behavior

  2018cites this paper
• Adolescents et tabac

  2018cites this paper
• Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction

  2017cites this paper
• Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer

  2017cites this paper
• Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans

  2017cites this paper
• CYP2A6 Genetic Variation Alters Striatal-Cingulate Circuits, Network Hubs, and Executive Processing in Smokers.

  2017cites this paper
• Interaction between cytochrome P450 2A6 and Catechol-O-Methyltransferase genes and their association with smoking risk in young men

  2017cites this paper
• Variation in CYP2A6 Activity and Personalized Medicine

  2017cites this paper
• Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not?

  2017cites this paper
• Pharmacogenetic Optimization of Smoking Cessation Treatment.

  2017cites this paper
• CYP2A6 Longitudinal Effects in Young Smokers.

  2016cites this paper
• What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses.

  2016cites this paper
• To quit or not: Vulnerability of women to smoking tobacco

  2016cites this paper
• The Effect of Altering Brain CYP2B Activity on Nicotine Self-administration Behaviour and Nicotine Levels in the Brain

  2016cites this paper
• Actor-based Models of Substance Use in Adolescent Social Networks: Unravelling complex drivers of behaviour

  2016cites this paper
• Refining Associations between Targeted Genes and the Development of Substance Use Disorders

  2016cites this paper
• Physiology of EtOH, Opiate, Hypnotics, and Stimulants Receptors

  2016cites this paper
• Sources of Variation in Nicotine Metabolism and Associations with Smoking Abstinence in Adolescents and Adults

  2016cites this paper
• Inactivation of CYP2A6 by the Dietary Phenylpropanoid trans-Cinnamic Aldehyde (Cinnamaldehyde) and Estimation of Interactions with Nicotine and Letrozole

  2016cites this paper
• Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity

  2016cites this paper
• Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting.

  2016cites this paper
• Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers.

  2016cites this paper
• Associations of cytochrome P450 oxidoreductase genetic polymorphisms with smoking cessation in a Chinese population

  2016cites this paper
• Association of CYP2A6 gene polymorphisms with cigarette consumption: a meta-analysis.

  2015cites this paper
• Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers.

  2015cites this paper
• A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism

  2015cites this paper
• Variation in Nicotine and Nitrosamine Pharmacology Genes and Smoking-associated Lung Cancer

  2015cites this paper
• State-of-the-Art Office-Based Interventions to Eliminate Youth Tobacco Use: The Past Decade

  2015cites this paper
• Pharmacogenetics of nicotine and associated smoking behaviors.

  2015cites this paper
• The Genetics, Neurogenetics and Pharmacogenetics of Addiction

  2014cites this paper
• Where there is smoke, there is risk: Social and pharmacological exposure to smoking increase risk for smoking behavior during adolescence

  2014cites this paper
• Identification and Characterization of Novel CYP2A6 Variants in African American Slow Nicotine Metabolizers

  2014cites this paper
• Genetic Polymorphisms in Metabolizing Enzymes Modifying the Association Between Smoking and Inflammatory Bowel Diseases

  2014cites this paper
• Cohort Profile Cohort Profile : The Nicotine Dependence in Teens ( NDIT ) Study

  2014cites this paper
• Pharmacogenetics of chronic obstructive pulmonary disease.

  2013cites this paper
• II Intrapersonal / Individual Factors Associated With Tobacco-Related Health Disparities Chapter 3 Genetics , Physiological Processes , and Tobacco-Related Health Disparities

  year unknowncites this paper